Ocaratuzumab (Anti-CD20)
Product Specifications
CAS Number
1169956-08-4
Synonyms
AME 133v, LY 2469298
SKU
C00704-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) . MW: 145.38 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
201-02-1513 96 Tests
Mouse Transient Receptor Potential Cation Channel Subfamily V, Member 1 (TRPV1) ELISA Kit
Sign In for Pricing
View Details I8426-18B-AP 100 µL
Interleukin 4 (IL-4, B Cell Stimulatory Factor 1, BSF1, Binetrakin, HCGF, Hodgkin's Cell Growth Factor, IA Inducing Factor, Lymphocyte Stimulatory Factor 1, Macrophage Fusion Factor, Mast Cell Growth Factor 2, MCGF2, MFF, MGC79402, Pitrakinra, T Cell Growth Factor 2, TCGF2) (AP) discontinued
Sign In for Pricing
View Details 
033473-ML650 100 µL
CD1E, ID (CD1E, T-cell surface glycoprotein CD1e, membrane-associated, R2G1, CD1e, T-cell surface glycoprotein CD1e, soluble) (MaxLight 650) discontinued
Sign In for Pricing
View Details